Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-22-009370
Filing Date
2022-02-14
Accepted
2022-02-14 16:56:21
Documents
1
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 5 SUBMISSION doc5.html 5  
1 FORM 5 SUBMISSION doc5.xml 5 14494
  Complete submission text file 0001209191-22-009370.txt   15923
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3135 HUTTON DRIVE BEVERLY HILLS CA 90210
Business Address
Jakobovits Aya (Reporting) CIK: 0001823901 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-38359 | Film No.: 22634034